Concepedia

Rita Tohmé

RT

9

Publications

490

Citations

9

H-Index

2013

Active since

Affiliations

Cleveland Clinic(Current)

Case Western Reserve University

Icahn School of Medicine at Mount Sinai

Cleveland Clinic Lerner College of Medicine

Cancer Institute (WIA)

Rita Tohmé is an author at Cleveland Clinic specializing in medicine, cancer research, and cell biology.

ORCID

Top concepts

Publications per year

2013–2021

9

Publications

9

Activation of tumor suppressor protein PP2A inhibits KRAS-driven tumor growth

Jaya Sangodkar, Abbey Perl, Rita Tohmé et al. · Journal of Clinical Investigation · 2017 · 196 citations · Full text

, , +18

Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network

Xiaorong Gu, Rita Tohmé, Benjamin Tomlinson et al. · Leukemia · 2020 · 99 citations · Full text

Direct activation of PP2A for the treatment of tyrosine kinase inhibitor–resistant lung adenocarcinoma

Rita Tohmé, Sudeh Izadmehr, Sai Gandhe et al. · JCI Insight · 2019 · 68 citations · Full text

, , +17

A pilot clinical trial of the cytidine deaminase inhibitor tetrahydrouridine combined with decitabine to target DNMT1 in advanced, chemorefractory pancreatic cancer.

Davendra Sohal, Smitha Krishnamurthi, Rita Tohmé et al. · PubMed · 2020 · 29 citations · Full text

PBRM1 loss in kidney cancer unbalances the proximal tubule master transcription factor hub to repress proximal tubule differentiation

Xiaorong Gu, Francis Enane, Rita Tohmé et al. · Cell Reports · 2021 · 21 citations · Full text

, , +14

Rows per page

1–5 of 9